Document Detail


Activity of two different polyglucosamines, L112 and FF45, on body weight in male rats.
MedLine Citation:
PMID:  17482159     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
L112 and FF45 are two polyglucosamines with similar characteristics and molecular weights. Three groups of 15 young male rats each were fed a standard diet or a diet containing 2% L112 or FF45 for 4 weeks, and we measured their body weight; water and food intake; triglyceride and total, low-density lypoproteins (LDL) and high-density lypoproteins (HDL) cholesterol levels; and the amount of feces and fecal water and lipid concentrations. The results showed that both L112 and FF45 reduced the increase in body weight in comparison with controls (respectively 152+/-18.7 g and 155+/-18.7 g vs 166+/-18.1 g; ANOVA P<0.05). Total food intake during the study period was significantly greater in the animals treated with L112 or FF45 (respectively 780+/-49.9 g and 787+/-61.7 g vs 742+/-53.0 g), with a significant loss of "food efficiency". Water intake was similar in all three groups. There was no significant change in plasma lipid profiles in any of the groups except for a significant decrease in HDL cholesterol in the animals treated with L112. Twenty-four-hour fecal weight was 7.8+/-1.70 g in the controls, 10.1+/-1.98 g in the rats treated with L112, and 9.0+/-1.21 g in those treated with FF45 (Dunnet's test vs controls: P<0.05). Fecal lipid and water concentrations were significantly higher in the polyglucosamine-treated groups (P<0.05 Dunnet's test).
Authors:
Giampietro Bondiolotti; Silvio R Bareggi; Natale G Frega; Silvana Strabioli; Umberto Cornelli
Related Documents :
18932049 - Effect of dietary alpha-ketoglutarate on blood lipid profile during hypercholesterolaem...
8028519 - The effects of weight loss by exercise or by dieting on plasma high-density lipoprotein...
11770189 - Differential effects of raloxifene and continuous combined hormone replacement therapy ...
17401489 - Coronary fat content evaluated by morphometry in patients with severe atherosclerosis h...
17419879 - The lipid lowering effect of plant sterol ester capsules in hypercholesterolemic subjects.
17027569 - A population-based, cross-sectional comparison of lipid-related indexes for symptoms of...
21736779 - Supplement of bamboo extract lowers serum monocyte chemoattractant protein-1 concentrat...
9655589 - Influence of season on dietary composition, intake, and digestion by beef steers grazin...
20424219 - Exenatide affects circulating cardiovascular risk biomarkers independently of changes i...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2007-04-14
Journal Detail:
Title:  European journal of pharmacology     Volume:  567     ISSN:  0014-2999     ISO Abbreviation:  Eur. J. Pharmacol.     Publication Date:  2007 Jul 
Date Detail:
Created Date:  2007-05-28     Completed Date:  2007-07-27     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  1254354     Medline TA:  Eur J Pharmacol     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  155-8     Citation Subset:  IM    
Affiliation:
Department of Pharmacology, Chemotherapy and Medical Toxicology, School of Medicine, University of Milan, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Anti-Obesity Agents / pharmacology*
Body Weight / drug effects*
Chitosan / pharmacology*
Drinking / drug effects
Eating / drug effects
Feces / chemistry
Lipids / analysis
Male
Rats
Rats, Wistar
Water / analysis
Chemical
Reg. No./Substance:
0/Anti-Obesity Agents; 0/Lipids; 7732-18-5/Water; 9012-76-4/Chitosan

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Optimising the viability during storage of freeze-dried cell preparations of Campylobacter jejuni.
Next Document:  Pharmacodynamic characteristics and cardioprotective effects of new NHE1 inhibitors.